{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:04:02Z","timestamp":1792101842671,"version":"4.4.0"},"reference-count":6,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2026,8,1]]},"abstract":"<jats:p>This cohort study examines mortality, major cardiovascular events, and systemic complications in persons with hidradenitis suppurativa taking glucagon-like peptide-1 (GLP-1) receptor agonists.<\/jats:p>","DOI":"10.1001\/jamadermatol.2026.1907","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T15:33:58Z","timestamp":1782920038000},"page":"853","source":"Crossref","is-referenced-by-count":8,"title":["GLP-1 Receptor Agonist Use and Clinical Outcomes in Patients With Hidradenitis Suppurativa"],"prefix":"10.1001","volume":"162","author":[{"given":"Beata","family":"Jastrz\u0105b-Mi\u015bkiewicz","sequence":"first","affiliation":[{"name":"Division of Dermatology, Venereology and Clinical Immunology, Faculty of Medicine, Wroclaw University of Science and Technology, Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek C.","family":"Szepietowski","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Venereology and Clinical Immunology, Faculty of Medicine, Wroclaw University of Science and Technology, Wroclaw, Poland"},{"name":"Department of Dermatovenereology, 4th Military Hospital, Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr K.","family":"Krajewski","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Venereology and Clinical Immunology, Faculty of Medicine, Wroclaw University of Science and Technology, Wroclaw, Poland"},{"name":"Department of Dermatovenereology, 4th Military Hospital, Wroclaw, Poland"},{"name":"L\u00fcbeck Institute of Experimental Dermatology, University of L\u00fcbeck, L\u00fcbeck, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"6","key":"dld260015r1","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1111\/ijd.17186","article-title":"Risk of cardiovascular disorders in hidradenitis suppurativa patients: a large-scale, propensity-matched global retrospective cohort study.","volume":"63","author":"Krajewski","year":"2024","journal-title":"Int J Dermatol"},{"issue":"1","key":"dld260015r2","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3390\/cells13010065","article-title":"GLP1 receptor agonists\u2014effects beyond obesity and diabetes.","volume":"13","author":"Wilbon","year":"2023","journal-title":"Cells"},{"issue":"3","key":"dld260015r3","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies.","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"issue":"12","key":"dld260015r4","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1111\/jdv.20694","article-title":"The effects of GLP-1RA on inflammatory skin diseases: a comprehensive review.","volume":"39","author":"Paschou","year":"2025","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"dld260015r5","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s13578-025-01486-8","article-title":"Roles of glucagon-like peptide 1 receptor agonists in immune cell biology and autoimmune\/autoinflammatory diseases.","volume":"15","author":"Deng","year":"2025","journal-title":"Cell Biosci"},{"issue":"7","key":"dld260015r6","doi-asserted-by":"publisher","first-page":"4017","DOI":"10.1111\/dom.16424","article-title":"Glucagon-like peptide-1 receptor agonists lower risk of cardiovascular and non-cardiovascular mortality: a meta-analysis of eleven cardiovascular outcome trials.","volume":"27","author":"Kang","year":"2025","journal-title":"Diabetes Obes Metab"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2851182\/jamadermatology_jastrzbmikiewicz_2026_ld_260015_1786734793.37966.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T15:00:26Z","timestamp":1787151626000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2851182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,1]]},"references-count":6,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2026.1907","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,1]]}}}